Biblio
2014
Baccelli I, Stenzinger A, Vogel V, Pfitzner BMaria, Klein C, Wallwiener M, Scharpff M, Saini M, Holland-Letz T, Sinn H-P, et al. Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients. Oncotarget. 2014.